Odyssey Health, Inc. (ODYY) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
2300 WEST SAHARA AVENUE LAS VEGAS, NV 89102 |
| State of Incorp. | NV |
| Fiscal Year End | July 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 4/30/2024 MRQ | 1/31/2024 MRQ | 7/31/2023 | 7/31/2022 | 7/31/2021 | 7/31/2020 | 7/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 166,140 | 36,865 | 72,534 | 556,584 | 62,952 | 167,095 | |||
| Cash and cash equivalents | 166,140 | 36,865 | 72,534 | 556,584 | 62,952 | 167,095 | |||
| Receivables | 50,000 | ||||||||
| Prepaid expense | 53,535 | 36,667 | 302,833 | ||||||
| Other undisclosed current assets | 93,340 | 369,023 | 453,883 | ||||||
| Total current assets: | 259,480 | 405,888 | 526,417 | 610,119 | 99,619 | 519,928 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 414 | 965 | 1,517 | ||||||
| Intangible assets, net (including goodwill) | 49,905 | 43,260 | 5,000 | 23,139,570 | |||||
| Intangible assets, net (excluding goodwill) | 49,905 | 43,260 | 5,000 | 23,139,570 | |||||
| Other undisclosed noncurrent assets | 13,790,403 | ||||||||
| Total noncurrent assets: | 13,790,403 | 49,905 | 43,260 | 414 | 5,965 | 23,141,087 | |||
| TOTAL ASSETS: | 14,049,883 | 455,793 | 569,677 | 610,533 | 105,584 | 23,661,015 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 2,769,307 | 1,811,406 | 2,570,081 | 1,516,621 | 481,089 | 345,290 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | 110,063 | 32,351 | ||||
| Employee-related liabilities | ✕ | ✕ | ✕ | 896,700 | 259,487 | 211,702 | 297,547 | ||
| Accounts payable | 1,265,579 | 1,797,656 | 1,549,568 | 1,224,783 | 269,387 | 47,743 | |||
| Accrued liabilities | 1,503,728 | 13,750 | 13,750 | ||||||
| Debt | 1,385,138 | 2,019,660 | 1,180,000 | 736,240 | 225,973 | 784,913 | |||
| Business combination, contingent consideration, liability | 144,000 | ||||||||
| Due to related parties | ✕ | ✕ | ✕ | 125,000 | 2,568 | 27,902 | |||
| Other undisclosed current liabilities | 1,225,026 | 2,780,656 | 1,338,213 | 1,122,458 | (27,902) | ||||
| Total current liabilities: | 5,379,471 | 6,611,722 | 5,213,294 | 3,377,887 | 707,062 | 1,274,203 | |||
| Noncurrent Liabilities | |||||||||
| Other undisclosed noncurrent liabilities | 50,000 | ||||||||
| Total noncurrent liabilities: | 50,000 | ||||||||
| Total liabilities: | 5,379,471 | 6,611,722 | 5,213,294 | 3,377,887 | 757,062 | 1,274,203 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 8,670,412 | (6,155,929) | (4,643,617) | (2,767,354) | (651,478) | 22,386,812 | |||
| Common stock | 94,434 | 79,068 | 77,861 | 87,191 | 88,560 | 86,990 | |||
| Additional paid in capital | 55,997,277 | 53,862,378 | 49,456,476 | 42,879,278 | 28,110,689 | 23,821,124 | |||
| Accumulated deficit | (47,421,299) | (60,097,375) | (54,177,954) | (45,733,823) | (28,850,728) | (1,521,302) | |||
| Other undisclosed equity, attributable to parent | 1 | ||||||||
| Total equity: | 8,670,412 | (6,155,929) | (4,643,617) | (2,767,354) | (651,478) | 22,386,812 | |||
| TOTAL LIABILITIES AND EQUITY: | 14,049,883 | 455,793 | 569,677 | 610,533 | 105,584 | 23,661,015 | |||
Income Statement (P&L) (USD)
| 4/30/2024 TTM | 1/31/2024 TTM | 7/31/2023 | 7/31/2022 | 7/31/2021 | 7/31/2020 | 7/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Operating expenses | 89,114 | (2,323,704) | (8,106,580) | (6,420,712) | (3,846,663) | (378,143) | ||
| Other undisclosed operating loss | (3,843,501) | (2,990,311) | (9,440,000) | |||||
| Operating loss: | (3,754,387) | (5,314,015) | (8,106,580) | (15,860,712) | (3,846,663) | (378,143) | ||
| Nonoperating income (expense) | (1,324,025) | 8,677 | ||||||
| Investment income, nonoperating | (1,332,980) | |||||||
| Other nonoperating income | 8,955 | 8,677 | ||||||
| Interest and debt expense | (681,053) | (614,083) | (836,294) | (1,022,383) | (502,192) | (70,282) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 8,677 | |||||||
| Loss from continuing operations: | (5,750,788) | (5,919,421) | (8,942,874) | (16,883,095) | (4,348,855) | (448,425) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (8,942,874) | (16,883,095) | (4,348,855) | (448,425) | |
| Net loss: | (5,750,788) | (5,919,421) | (8,942,874) | (16,883,095) | (4,348,855) | (448,425) | ||
| Other undisclosed net income attributable to parent | 16,392,206 | 498,743 | ||||||
| Net income (loss) attributable to parent: | 10,641,418 | (5,919,421) | (8,444,131) | (16,883,095) | (4,348,855) | (448,425) | ||
| Other undisclosed net loss available to common stockholders, basic | (63,455) | |||||||
| Net income (loss) available to common stockholders, basic: | 10,577,963 | (5,919,421) | (8,444,131) | (16,883,095) | (4,348,855) | (448,425) | ||
| Interest on convertible debt | 52,946 | |||||||
| Convertible preferred dividends | 63,455 | |||||||
| Other undisclosed net income available to common stockholders, diluted | 87,597 | |||||||
| Net income (loss) available to common stockholders, diluted: | 10,781,961 | (5,919,421) | (8,444,131) | (16,883,095) | (4,348,855) | (448,425) | ||
Comprehensive Income (USD)
| 4/30/2024 TTM | 1/31/2024 TTM | 7/31/2023 | 7/31/2022 | 7/31/2021 | 7/31/2020 | 7/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (5,750,788) | (5,919,421) | (8,942,874) | (16,883,095) | (4,348,855) | (448,425) | ||
| Comprehensive loss, net of tax, attributable to parent: | (5,750,788) | (5,919,421) | (8,942,874) | (16,883,095) | (4,348,855) | (448,425) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.